🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

GUSS-ICU Safe Nutrition Program After Extubation in ICU Patients

RecruitingNAAges 18 Years - anyAllIstanbul University - Cerrahpasa
NCT07195383 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to evaluate the effects of using the GUSS-ICU Safe Nutrition Program after extubation in Intensive Care Unit patients. This randomized controlled trial will be conducted in the Anesthesia Intensive Care Unit of Bakırköy Dr. Sadi Konuk Training and Research Hospital. Eligible participants will be randomly assigned to either the control group (usual care/routine follow-up group) or the intervention group (GUSS-ICU patients). Patients undergoing GUSS-ICU assessment will continue the nutritional program, as directed by the scale, for four days. Data are recorded on the first and last day. The data will then be evaluated in conjunction with the control group data.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Age 18 and over Patients expected to remain intubated for more than 24 hours. Patients who have been extubated for no more than 4 hours. Exclusion Criteria: * Patients with neuromuscular disease * Patients requiring non-invasive ventilation for more than 6 hours after extubation * Patients being followed in the terminal phase * Patients with a tracheostomy cannula * Patients with a history of dysphagia * Patients with head/neck cancer or surgery * Patients with existing facial fractures * Patients with a RASS score not within the 0-2 range * Patients at high risk of bleeding (INR ≥ 2.0, Platelet count ≤ 50,000).
💊

What it tests

  • Nutrion plan based on GUSS-ICU scale
📍

Where

2 sites
Bakırköy Dr. Sadi Konuk Training and Research Hospital
Istanbul, Turkey (Türkiye)
Istanbul Universitesi-Cerrahpasa
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy